Eloxx Pharmaceuticals, Inc.
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2016 | 12.6M |
| FY2017 | 82.6M |
| FY2018 | 107.6M |
| FY2019 | 120.1M |
| FY2020 | 120.5M |
| FY2021 | 5.2M |
| FY2022 | 6.5M |
| FY2023 | 2.6M |
| FY2024 | 3.8M |
| FY2025 | 12.3M |
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2016 | 12.6M |
| FY2017 | 82.6M |
| FY2018 | 107.6M |
| FY2019 | 120.1M |
| FY2020 | 120.5M |
| FY2021 | 5.2M |
| FY2022 | 6.5M |
| FY2023 | 2.6M |
| FY2024 | 3.8M |
| FY2025 | 12.3M |